🔓
Sign in as a Member to unlock the full view of DGX. · Full hedge fund list, every line-item carveout, cabinet conflicts, and politicians-trading detail.
Become a Member$24.50/mo already a Member? Sign in →
DGX

Quest Diagnostics Incorporated

Sector: healthcareMedical - Diagnostics & ResearchNYSEMarket Cap: $22.52B

Quest Diagnostics (DGX) is a clinical laboratory services provider with $703M in federal contracts and 8 congressional traders, including Rep. Michael McCaul (R-TX) with $984K in buys.

Govt Dependence
65/100
Regulatory Density
80/100
Lobbying Intensity
40/100
Political Signal
BULLISH

BusinessWhat DGX does

Quest Diagnostics provides diagnostic testing, information, and services to patients, clinicians, hospitals, employers, and health plans. Revenue lines include clinical testing, anatomic pathology, and esoteric testing, with significant federal contract revenue from agencies like the Department of Defense and Department of Health and Human Services.

12 months past · 3 months futureDGX activity timeline

$246$204$162 AugSepOctNovDecJan '26FebMarAprMayJunJulAugSepOct ↓ PAST — recorded activity ↑ FUTURE — scheduled markups · pending votes TODAY · Jul 28 $239.08 hi $167.41 lo $239.08 CONGRESS 30 INSIDERS 0 13F FUNDS 30 BILLS 28 Ro Khanna (D) · Purchase · 2026-01-29Julie Johnson (D) · Sale · 2025-11-03 D.E. Shaw & Co. · OPENED $57M · 2025-12-31Citadel Advisors · + $44M · 2025-12-31Citadel Advisors · + $25M · 2025-09-30Two Sigma Investments · OPENED $8M · 2025-12-31Bridgewater Associates · + $1M · 2025-09-30Bridgewater Associates · - $1M · 2025-12-31 S.827 · markup · 2025-07-30HR.2001 · committee · 2026-07-21HR.1860 · committee · 2025-09-16 MARKUP · Senate Health, Education, Labor, and Pensions Subcommittee o · 2026-07-29MARKUP · Senate Health, Education, Labor, and Pensions · 2026-07-30MARKUP · Senate Budget · 2026-08-04
Congress
buy sell
Insider · Form 4
open-market buy
Hedge fund · 13F
opened + added − trimmed closed holds
Bills
past action (this ticker) upcoming markup (sector) carveout (this ticker)
251 trading days · 2 congressional trades shown · 0 insider buys · 6 13F filings · 3 past bill actions · 3 upcoming markups

Executive Branch ConflictsDGX held by Trump-administration officials

1 cabinet/senior official reported DGX positions in OGE Form 278 disclosures across 1 filings.

Lifetime Government AwardsDGX federal contracts by year

$224M
total awarded · 2002–2014
1000
contracts on file
2013
peak year ($70M)
$70M $35M 2002: $14K across 1 contract $14K 2002 2004: $11K across 1 contract $11K 2004 2005: $17K across 2 contracts $17K 2005 2 contracts 2007: $12M across 10 contracts $12M 2007 10 contracts 2008: $3M across 12 contracts $3M 2008 12 contracts 2009: $4M across 25 contracts $4M 2009 25 contracts 2010: $17M across 48 contracts $17M 2010 48 contracts 2011: $41M across 154 contracts $41M 2011 154 contracts 2012: $68M across 323 contracts $68M 2012 323 contracts 2013: $70M across 332 contracts (peak year) $70M 2013 332 contracts 2014: $9M across 92 contracts $9M 2014 92 contracts
Top contracts by award amount
$11.6M Department of Veterans Affairs 2007-10-01 LABORATORY TESTING SERVICES FOR VISN 1
$4.8M Department of Veterans Affairs 2013-09-30 IGF::CT::IGF CRITICAL FUNCTION - BLOOD DRAWS/COURIER SERVICE AND TESTI
$3.1M Department of Veterans Affairs 2012-10-27 LAB TESTING FOR KANSAS CITY VAMC
$2.7M Department of Veterans Affairs 2013-10-01 IGF::CT::IGF REFERENCE LABORATORY TESTING (675-C40012)
$2.5M Department of Veterans Affairs 2012-10-27 LAB TESTING FOR THE MARION VAMC. IGF::OT::IGF CORRECTION TO FORCE NAIC
13 years · 1000 contracts

Smart Money · 13F HoldingsHedge funds holding DGX

$101.9M
Total DGX held by tracked 13F funds
3
Funds with DGX positions
+1
Funds opened this quarter
D.E. Shaw & Co. $57M opened 2 overlap 2025-12-31
Citadel Advisors $44M +95% 2 overlap 2025-12-31
Bridgewater Associates $610K -38% 2 overlap 2025-12-31

Politicians Trading DGXMembers of Congress with recent DGX positions

4 politicians traded DGX across 12 disclosed transactions totaling $96K (last 730 days). Greed score = composite of trade frequency, volume & recency across the politician's entire history (not just DGX). 0-30 LOW · 30-60 MID · 60+ HIGH.

Congressional TradesWho in Congress is trading DGX

2026-01-29 Ro Khanna D-California · house Purchase $1,001 - $15,000
2025-07-24 Julia Letlow R-Louisiana · house Sale $1,001 - $15,000 173d late
2025-04-28 Julia Letlow R-Louisiana · house Purchase $1,001 - $15,000 260d late
2025-11-03 Julie Johnson D-Texas · house Sale $1,001 - $15,000
2025-03-10 Carol D. Miller R-West Virginia · house Sale $1,001 - $15,000
2025-03-10 Carol D. Miller R-West Virginia · house sale $1,001 - $15,000
2025-01-17 Ro Khanna D-California · house Purchase $1,001 - $15,000
2025-01-17 Ro Khanna D-California · house purchase $1,001 - $15,000
2024-11-15 Ro Khanna D-California · house Purchase $1,001 - $15,000
2024-11-12 Ro Khanna D-California · house Purchase $1,001 - $15,000
2024-11-12 Ro Khanna D-California · house purchase $1,001 - $15,000
2024-11-15 Ro Khanna D-California · house purchase $1,001 - $15,000
30+ trades on file · most recent 2026-02-06

Corporate Insiders · Form 4What CEOs, CFOs, and directors are doing with their own stock

No Form 4 activity recorded in the last 180 days.

Bills Affecting DGXLive legislation impacting this stock

Political ProfileWhere DGX sits in Washington

[object Object]

STRUCTURAL: 8 congressional traders with committee alignment (e.g., Rep. Letlow chairs HHS Appropriations subcommittee), $160K lobbying on Medicare payment delays, $703M federal contracts across 7 agencies. EVIDENTIARY: Rep. McCaul's $984K in buys, Rep. Khanna's $200K buys, and Trump executive branch holding. Net: Strong structural support with evidentiary buys, though no corporate insider buys.

Regulatory ExposureThreats & opportunities

Regulatory threats

  • Medicare payment cuts for laboratory services
    Centers for Medicare & Medicaid Services (CMS)
    "get_political_influence.lobbying_patterns[0].lobbying_events show lobbying on 'delay to certain cuts to laboratory payments covered by Medicare'"
  • FDA regulation of laboratory developed tests (LDTs)
    Food and Drug Administration (FDA)
    "get_political_influence.lobbying_filings[0].specific_issues includes 'Rules and regulations related to FDA's treatment of certain laboratory developed tests'"

Regulatory opportunities

  • Funding for syphilis crisis testing and PFAS testing programs
    Department of Health and Human Services
    "get_political_influence.lobbying_filings[0].specific_issues includes 'Issues related to combatting the syphilis crisis... and testing for PFAS'"
  • Support for Cancer Moonshot initiative testing
    National Institutes of Health
    "get_political_influence.lobbying_filings[0].specific_issues includes 'Issues related to the Cancer Moonshot initiative'"

Capitol Hill AlliesChampions & critics

Congressional champions

Congressional critics

  • No specific congressional critics identified.

LobbyingWho's hired to advocate for DGX

RED+BLUE STRATEGIES · $160K healthcare
Member intelligence layer

Live signals + predictions for DGX — for Founders

The free page above gives you the public record. Members see the real-time intelligence layer on top of it:

Become a Founder · $24.50/mo Locked rate forever · cancel anytime

Frequently AskedAbout DGX & political exposure

Does Quest Diagnostics Incorporated (DGX) hold federal contracts?
Yes. Quest Diagnostics Incorporated has 6411 federal contract awards totaling $1,448,644,210, primarily from agencies including Court Services and Offender Supervision Agency, Defense Nuclear Facilities Safety Board, Department of Agriculture. See full contract list and amounts on this page.
Which Trump cabinet officials own DGX stock?
1 Trump cabinet members or senior White House staff have disclosed holdings in DGX on their OGE 278 financial disclosures, including Donald J. Trump. See the Cabinet Conflicts panel for details.
Has Congress traded DGX stock?
176 congressional trades by 16 unique members of Congress, most recently on 2026-01-29. See the Congressional Trading panel for politician-by-politician breakdown.
What is DGX political risk profile?
Government dependence: 65/100. Lobbying intensity: 40/100. Political signal: bullish. Donor party split: R 0% / D 0%.
How does GovGreed track DGX political activity?
GovGreed integrates STOCK Act congressional trade disclosures, FEC contributions, OGE executive-branch disclosures, USASpending federal contracts, Senate LDA lobbying filings, and SEC Form 4 corporate insider trades into a single queryable graph. DGX data is updated daily from these official federal sources.